|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006098,
umls-concept:C0033572,
umls-concept:C0034380,
umls-concept:C0036864,
umls-concept:C0042034,
umls-concept:C0205314,
umls-concept:C0449445,
umls-concept:C0542341,
umls-concept:C0600558,
umls-concept:C0679622,
umls-concept:C1522673
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2003-2-24
|
|
pubmed:abstractText |
Data demonstrate a benefit from neoadjuvant and adjuvant hormone-deprivation therapy with luteinizing hormone-releasing hormone agonists in patients who are treated with radiotherapy for localized prostate carcinoma; however, this approach has detrimental effects on quality of life (QOL). A cross-sectional study was undertaken to evaluate the impact on QOL, voiding function, and sexual function of an alternative hormone-deprivation approach.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2003 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
97
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1203-10
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12599226-5-alpha Reductase Inhibitors,
pubmed-meshheading:12599226-Adenocarcinoma,
pubmed-meshheading:12599226-Aged,
pubmed-meshheading:12599226-Androgen Antagonists,
pubmed-meshheading:12599226-Anilides,
pubmed-meshheading:12599226-Brachytherapy,
pubmed-meshheading:12599226-Chemotherapy, Adjuvant,
pubmed-meshheading:12599226-Diarrhea,
pubmed-meshheading:12599226-Enzyme Inhibitors,
pubmed-meshheading:12599226-Finasteride,
pubmed-meshheading:12599226-Flutamide,
pubmed-meshheading:12599226-Humans,
pubmed-meshheading:12599226-Logistic Models,
pubmed-meshheading:12599226-Male,
pubmed-meshheading:12599226-Nitriles,
pubmed-meshheading:12599226-Penile Erection,
pubmed-meshheading:12599226-Prostatic Neoplasms,
pubmed-meshheading:12599226-Quality of Life,
pubmed-meshheading:12599226-Tosyl Compounds,
pubmed-meshheading:12599226-Treatment Outcome,
pubmed-meshheading:12599226-Urinary Incontinence
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapy.
|
|
pubmed:affiliation |
Department of Urology, University of Virginia Health Sciences Center, Charlottesville 22908, USA.
|
|
pubmed:publicationType |
Journal Article
|
